Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 4526651015 | Naxitamab (substance) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 4526652010 | Naxitamab | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 5092081000052111 | naxitamab | sv | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Naxitamab (substance) | Is a | Monoclonal antibody | true | Inferred relationship | Some | ||
| Naxitamab (substance) | Is a | Antineoplastic agent (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Naxitamab-containing product | Has active ingredient | True | Naxitamab (substance) | Inferred relationship | Some | 1 |
| Product containing only naxitamab (medicinal product) | Has active ingredient | True | Naxitamab (substance) | Inferred relationship | Some | 1 |
| Naxitamab-containing product in parenteral dose form | Has active ingredient | True | Naxitamab (substance) | Inferred relationship | Some | 1 |
| Product containing only naxitamab in parenteral dose form (medicinal product form) | Has active ingredient | True | Naxitamab (substance) | Inferred relationship | Some | 1 |
Reference Sets
FHIR